Jim Simons Recursion Pharmaceuticals, Inc. Transaction History

Renaissance Technologies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$4.56 - $9.94 $298,958 - $651,676	-65,561 Reduced 15.78%	350,000 $2.62 Million
Q1 2023 May 12, 2023	BUY	$6.42 - $9.64 $1.42 Million - $2.14 Million	221,661 Added 114.32%	415,561 $2.77 Million
Q4 2022 Feb 13, 2023	BUY	$7.16 - $12.7 $1.28 Million - $2.27 Million	178,700 Added 1175.66%	193,900 $1.5 Million
Q3 2022 Nov 14, 2022	SELL	$7.83 - $13.6 $1.93 Million - $3.35 Million	-246,400 Reduced 94.19%	15,200 $162,000
Q2 2022 Aug 12, 2022	BUY	$5.04 - $9.26 $419,328 - $770,432	83,200 Added 46.64%	261,600 $2.13 Million
Q1 2022 May 13, 2022	BUY	$6.16 - $18.03 $1.1 Million - $3.22 Million	178,400 New	178,400 $1.28 Million

286

242M

1.35M

2.32M

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.41B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.